{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:52:02Z","timestamp":1777650722069,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T00:00:00Z","timestamp":1336521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum Genet"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00439-012-1175-1","type":"journal-article","created":{"date-parts":[[2012,5,8]],"date-time":"2012-05-08T08:27:47Z","timestamp":1336465667000},"page":"1375-1391","source":"Crossref","is-referenced-by-count":18,"title":["Reduced interferon (IFN)-\u03b1 conditioned by IFNA2 (\u2212173) and IFNA8 (\u2212884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality"],"prefix":"10.1007","volume":"131","author":[{"given":"Prakasha","family":"Kempaiah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel B.","family":"Anyona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evans","family":"Raballah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory C.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Were","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Hittner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Ong\u2019echa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas J.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,9]]},"reference":[{"key":"1175_CR1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(02)08273-9","volume":"359","author":"M Aidoo","year":"2002","unstructured":"Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, Nahlen BL, Lal AA, Udhayakumar V (2002) Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 359:1311\u20131312","journal-title":"Lancet"},{"key":"1175_CR2","first-page":"461","volume":"72","author":"NM Anstey","year":"2002","unstructured":"Anstey NM, Boutlis CS, Saunders JR (2002) Systemic nitric oxide production in human malaria. I. Analysis of NO metabolites in biological fluids. Methods Mol Med 72:461\u2013467","journal-title":"Methods Mol Med"},{"key":"1175_CR3","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1128\/IAI.05601-11","volume":"79","author":"SB Anyona","year":"2011","unstructured":"Anyona SB, Kempaiah P, Raballah E, Ouma C, Were T, Davenport GC, Konah SN, Vulule JM, Hittner JB, Gichuki CW, Ong\u2019echa JM, Perkins DJ (2011) Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality. Infect Immun 79:4923\u20134932","journal-title":"Infect Immun"},{"key":"1175_CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ajh.21933","volume":"86","author":"GA Awandare","year":"2011","unstructured":"Awandare GA, Kempaiah P, Ochiel DO, Piazza P, Keller CC, Perkins DJ (2011) Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model. Am J Hematol 86:155\u2013162","journal-title":"Am J Hematol"},{"key":"1175_CR5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4269\/ajtmh.1994.50.529","volume":"50","author":"JC Beier","year":"1994","unstructured":"Beier JC, Oster CN, Onyango FK, Bales JD, Sherwood JA, Perkins PV, Chumo DK, Koech DV, Whitmire RE, Roberts CR et al (1994) Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am J Trop Med Hyg 50:529\u2013536","journal-title":"Am J Trop Med Hyg"},{"key":"1175_CR6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/jir.1997.17.625","volume":"17","author":"MW Beilharz","year":"1997","unstructured":"Beilharz MW, McDonald W, Watson MW, Heng J, McGeachie J, Lawson CM (1997) Low-dose oral type I interferons reduce early virus replication of murine cytomegalovirus in vivo. J Interf Cytokine Res 17:625\u2013630","journal-title":"J Interf Cytokine Res"},{"key":"1175_CR7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/08977190400000833","volume":"22","author":"J Bekisz","year":"2004","unstructured":"Bekisz J, Schmeisser H, Hernandez J, Goldman ND, Zoon KC (2004) Human interferons alpha, beta and omega. Growth Factors 22:243\u2013251","journal-title":"Growth Factors"},{"key":"1175_CR8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S1369-5274(99)80066-6","volume":"2","author":"CA Biron","year":"1999","unstructured":"Biron CA (1999) Initial and innate responses to viral infections\u2014pattern setting in immunity or disease. Curr Opin Microbiol 2:374\u2013381","journal-title":"Curr Opin Microbiol"},{"key":"1175_CR9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1074-7613(01)00154-6","volume":"14","author":"CA Biron","year":"2001","unstructured":"Biron CA (2001) Interferons alpha and beta as immune regulators: a new look. Immunity 14:661\u2013664","journal-title":"Immunity"},{"key":"1175_CR10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4269\/ajtmh.1999.60.635","volume":"60","author":"PB Bloland","year":"1999","unstructured":"Bloland PB, Ruebush TK, McCormick JB, Ayisi J, Boriga DA, Oloo AJ, Beach R, Hawley W, Lal A, Nahlen B, Udhayakumar V, Campbell CC (1999) Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population. Am J Trop Med Hyg 60:635\u2013640","journal-title":"Am J Trop Med Hyg"},{"key":"1175_CR11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0952-7915(00)00111-4","volume":"12","author":"C Bogdan","year":"2000","unstructured":"Bogdan C (2000) The function of type I interferons in antimicrobial immunity. Curr Opin Immunol 12:419\u2013424","journal-title":"Curr Opin Immunol"},{"key":"1175_CR12","doi-asserted-by":"crossref","first-page":"604S","DOI":"10.1093\/jn\/131.2.604S","volume":"131","author":"BJ Brabin","year":"2001","unstructured":"Brabin BJ, Hakimi M, Pelletier D (2001) An analysis of anemia and pregnancy-related maternal mortality. J Nutr 131:604S\u2013614S discussion 614S-615S","journal-title":"J Nutr"},{"key":"1175_CR13","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.178.5.1655","volume":"178","author":"V Brinkmann","year":"1993","unstructured":"Brinkmann V, Geiger T, Alkan S, Heusser CH (1993) Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med 178:1655\u20131663","journal-title":"J Exp Med"},{"key":"1175_CR67","unstructured":"CHIP_bioinformatics. http:\/\/snpper.chip.org\/bio\/snpper-enter"},{"key":"1175_CR14","unstructured":"Court M (2008) http:\/\/www.tufts.edu\/~mcourt01\/Documents\/Court%20lab%20-%20HW%20calculator.xls"},{"key":"1175_CR15","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.4049\/jimmunol.152.9.4649","volume":"152","author":"JJ Ferbas","year":"1994","unstructured":"Ferbas JJ, Toso JF, Logar AJ, Navratil JS, Rinaldo CR Jr (1994) CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. J Immunol 152:4649\u20134662","journal-title":"J Immunol"},{"key":"1175_CR16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/jir.1996.16.1027","volume":"16","author":"GR Foster","year":"1996","unstructured":"Foster GR, Rodrigues O, Ghouze F, Schulte-Frohlinde E, Testa D, Liao MJ, Stark GR, Leadbeater L, Thomas HC (1996) Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency. J Interf Cytokine Res 16:1027\u20131033","journal-title":"J Interf Cytokine Res"},{"key":"1175_CR17","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.4049\/jimmunol.156.7.2481","volume":"156","author":"ML Francis","year":"1996","unstructured":"Francis ML, Fan XS, Meltzer MS (1996) Loss ability to produce IFN-alpha in response to HIV-1 as monocytes differentiate into macrophages. Induction through a mechanism independent of double-stranded RNA. J Immunol 156:2481\u20132487","journal-title":"J Immunol"},{"key":"1175_CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/BA20060211","volume":"48","author":"JC Garcia","year":"2007","unstructured":"Garcia JC, Ariza AM, Lasa AM, Gonzalez LJ, Perez VB (2007) Increased antiviral activity of microscale-purified HuIFN alpha 8 (human interferon alpha 8) over HuIFN alpha 2b in Hep-2 cells challenged with Mengo virus. Biotechnol Appl Biochem 48:159\u2013165","journal-title":"Biotechnol Appl Biochem"},{"key":"1175_CR19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1471-2105-7-227","volume":"7","author":"TRRS Gaunt","year":"2006","unstructured":"Gaunt TRRS, Zapata C, Day IN (2006) MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers. BMC Bioinf 7:227","journal-title":"BMC Bioinf"},{"key":"1175_CR20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4269\/ajtmh.2011.10-0678","volume":"85","author":"MJ Hamel","year":"2011","unstructured":"Hamel MJ, Adazu K, Obor D, Sewe M, Vulule J, Williamson JM, Slutsker L, Feikin DR, Laserson KF (2011) A reversal in reductions of child mortality in western Kenya, 2003\u20132009. Am J Trop Med Hyg 85:597\u2013605","journal-title":"Am J Trop Med Hyg"},{"key":"1175_CR21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0042-6822(78)90068-5","volume":"89","author":"EA Havell","year":"1978","unstructured":"Havell EA, Hayes TG, Vilcek J (1978) Synthesis of two distinct interferons by human fibroblasts. Virology 89:330\u2013334","journal-title":"Virology"},{"key":"1175_CR22","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1189\/jlb.0603255","volume":"74","author":"A Izaguirre","year":"2003","unstructured":"Izaguirre A, Barnes BJ, Amrute S, Yeow WS, Megjugorac N, Dai J, Feng D, Chung E, Pitha PM, Fitzgerald-Bocarsly P (2003) Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J Leukoc Biol 74:1125\u20131138","journal-title":"J Leukoc Biol"},{"key":"1175_CR23","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1128\/IAI.72.8.4868-4873.2004","volume":"72","author":"CC Keller","year":"2004","unstructured":"Keller CC, Kremsner PG, Hittner JB, Misukonis MA, Weinberg JB, Perkins DJ (2004) Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells. Infect Immun 72:4868\u20134873","journal-title":"Infect Immun"},{"issue":"9","key":"1175_CR24","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/IAI.00342-09","volume":"77","author":"CCOC Keller","year":"2009","unstructured":"Keller CCOC, Ouma Y, Awandare GA, Davenport GC, Were T, Hittner JB, Vulule JM, Ong\u2019echa JM, Perkins DJ (2009a) Suppression of a novel hematopoietic mediator in children with severe malarial anemia. Infect Immun 77(9):3864\u20133871","journal-title":"Infect Immun"},{"issue":"9","key":"1175_CR25","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/IAI.00342-09","volume":"77","author":"CC Keller","year":"2009","unstructured":"Keller CC, Ouma C, Ouma Y, Awandare GA, Davenport GC, Were T, Hittner JB, Vulule JM, Ong\u2019echa JM, Perkins DJ (2009b) Suppression of a novel hematopoietic mediator in children with severe malarial anemia. Infect Immun 77(9):3864\u20133871","journal-title":"Infect Immun"},{"key":"1175_CR26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/322037","volume":"184","author":"JF Kun","year":"2001","unstructured":"Kun JF, Mordmuller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, Weinberg JB, Kremsner PG (2001) Nitric oxide synthase 2(Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis 184:330\u2013336","journal-title":"J Infect Dis"},{"key":"1175_CR27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2141.1997.82654.x","volume":"97","author":"JA Kurtzhals","year":"1997","unstructured":"Kurtzhals JA, Rodrigues O, Addae M, Commey JO, Nkrumah FK, Hviid L (1997) Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol 97:169\u2013174","journal-title":"Br J Haematol"},{"key":"1175_CR28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1086\/432519","volume":"77","author":"DP Kwiatkowski","year":"2005","unstructured":"Kwiatkowski DP (2005) How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 77:171\u2013192","journal-title":"Am J Hum Genet"},{"key":"1175_CR29","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/IAI.68.7.3909-3915.2000","volume":"68","author":"AJ Luty","year":"2000","unstructured":"Luty AJ, Perkins DJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek P, Herbich K, Schmid D, Weinberg JB, Kremsner PG (2000) Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun 68:3909\u20133915","journal-title":"Infect Immun"},{"key":"1175_CR30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","volume":"27","author":"FO Martinez","year":"2009","unstructured":"Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451\u2013483","journal-title":"Annu Rev Immunol"},{"key":"1175_CR31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4269\/ajtmh.1999.61.932","volume":"61","author":"PD McElroy","year":"1999","unstructured":"McElroy PD, Lal AA, Hawley WA, Bloland PB, Kuile FO, Oloo AJ, Harlow SD, Lin X, Nahlen BL (1999) Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asemobo Bay Cohort Project. Am J Trop Med Hyg 61:932\u2013940","journal-title":"Am J Trop Med Hyg"},{"key":"1175_CR32","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4269\/ajtmh.2000.62.504","volume":"62","author":"PD McElroy","year":"2000","unstructured":"McElroy PD, ter Kuile FO, Lal AA, Bloland PB, Hawley WA, Oloo AJ, Monto AS, Meshnick SR, Nahlen BL (2000) Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. The Asembo Bay Cohort Project. Am J Trop Med Hyg 62:504\u2013512","journal-title":"Am J Trop Med Hyg"},{"key":"1175_CR33","first-page":"1165","volume":"12","author":"S Mori","year":"1998","unstructured":"Mori S, Jewett A, Cavalcanti M, Murakami-Mori K, Nakamura S, Bonavida B (1998) Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA\/ionomycin. Int J Oncol 12:1165\u20131170","journal-title":"Int J Oncol"},{"key":"1175_CR34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4314\/eamj.v85i7.9649","volume":"85","author":"T Muasya","year":"2008","unstructured":"Muasya T, Lore W, Yano K, Yatsuhashi H, Owiti FR, Fukuda M, Tamada MY, Kulundu J, Tukei J, Okoth FA (2008) Prevalence of hepatitis C virus and its genotypes among a cohort of drug users in Kenya. East Afr Med J 85:318\u2013325","journal-title":"East Afr Med J"},{"key":"1175_CR35","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","volume":"264","author":"U Muller","year":"1994","unstructured":"Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M (1994) Functional role of type I and type II interferons in antiviral defense. Science 264:1918\u20131921","journal-title":"Science"},{"key":"1175_CR36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(12)60034-8","volume":"379","author":"CJ Murray","year":"2012","unstructured":"Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. The Lancet 379:413\u2013431","journal-title":"The Lancet"},{"key":"1175_CR37","unstructured":"NCBI_refSNP. http:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?rs=16938369and1096498"},{"key":"1175_CR38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2458-6-132","volume":"6","author":"M Ndiritu","year":"2006","unstructured":"Ndiritu M, Cowgill KD, Ismail A, Chiphatsi S, Kamau T, Fegan G, Feikin DR, Newton CR, Scott JA (2006) Immunization coverage and risk factors for failure to immunize within the expanded programme on immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens. BMC Public Health 6:132","journal-title":"BMC Public Health"},{"key":"1175_CR39","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2141.2010.08147.x","volume":"149","author":"EM Novelli","year":"2010","unstructured":"Novelli EM, Hittner JB, Davenport GC, Ouma C, Were T, Obaro S, Kaplan S, Ong\u2019echa JM, Perkins DJ (2010) Clinical predictors of severe malarial anaemia in a holoendemic Plasmodium falciparum transmission area. Br J Haematol 149:711\u2013721","journal-title":"Br J Haematol"},{"key":"1175_CR40","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4269\/ajtmh.1998.59.808","volume":"59","author":"CO Obonyo","year":"1998","unstructured":"Obonyo CO, Steyerberg EW, Oloo AJ, Habbema JD (1998) Blood transfusions for severe malaria-related anemia in Africa: a decision analysis. Am J Trop Med Hyg 59:808\u2013812","journal-title":"Am J Trop Med Hyg"},{"key":"1175_CR41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4314\/eamj.v81i1.8795","volume":"81","author":"FN Okwara","year":"2004","unstructured":"Okwara FN, Obimbo EM, Wafula EM, Murila FV (2004) Bacteraemia, urinary tract infection and malaria in hospitalised febrile children in Nairobi: is there an association? East Afr Med J 81:47\u201351","journal-title":"East Afr Med J"},{"key":"1175_CR42","doi-asserted-by":"crossref","unstructured":"Ong\u2019echa JM, Davenport G, Vulule JM, Hittner JB, Perkins DJ (2011) Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods. Infect Immun (Epub ahead of print)","DOI":"10.1128\/IAI.05161-11"},{"key":"1175_CR43","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4269\/ajtmh.2006.74.376","volume":"74","author":"JM Ong\u2019echa","year":"2006","unstructured":"Ong\u2019echa JM, Keller CC, Were T, Ouma C, Otieno RO, Landis-Lewis Z, Ochiel D, Slingluff JL, Mogere S, Ogonji GA, Orago AS, Vulule JM, Kaplan SS, Day RD, Perkins DJ (2006) Parasitemia, anemia, and malarial anemia in infants and young children in a rural holoendemic Plasmodium falciparum transmission area. Am J Trop Med Hyg 74:376\u2013385","journal-title":"Am J Trop Med Hyg"},{"key":"1175_CR44","doi-asserted-by":"crossref","unstructured":"Ong\u2019echa JM, Davenport GC, Vulule JM, Hittner JB, Perkins DJ (2011) Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods. Infect Immun (Epub ahead of print)","DOI":"10.1128\/IAI.05161-11"},{"key":"1175_CR45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/314548","volume":"179","author":"C Othoro","year":"1999","unstructured":"Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, Udhayakumar V (1999) A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis 179:279\u2013282","journal-title":"J Infect Dis"},{"key":"1175_CR46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.aids.0000200533.56490.b7","volume":"20","author":"RO Otieno","year":"2006","unstructured":"Otieno RO, Ouma C, Ong\u2019echa JM, Keller CC, Were T, Waindi EN, Michaels MG, Day RD, Vulule JM, Perkins DJ (2006) Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS 20:275\u2013280","journal-title":"AIDS"},{"key":"1175_CR47","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4269\/ajtmh.2006.74.573","volume":"74","author":"C Ouma","year":"2006","unstructured":"Ouma C, Keller CC, Opondo DA, Were T, Otieno RO, Otieno MF, Orago AS, Ong\u2019Echa JM, Vulule JM, Ferrell RE, Perkins DJ (2006) Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young children. Am J Trop Med Hyg 74:573\u2013577","journal-title":"Am J Trop Med Hyg"},{"key":"1175_CR48","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1086\/592055","volume":"198","author":"C Ouma","year":"2008","unstructured":"Ouma C, Davenport GC, Awandare GA, Keller CC, Were T, Otieno MF, Vulule JM, Martinson J, Ong\u2019echa JM, Ferrell RE, Perkins DJ (2008) Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production. J Infect Dis 198:1219\u20131226","journal-title":"J Infect Dis"},{"key":"1175_CR49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/IAI.00895-09","volume":"78","author":"C Ouma","year":"2010","unstructured":"Ouma C, Keller CC, Davenport GC, Were T, Konah S, Otieno MF, Hittner JB, Vulule JM, Martinson J, Ong\u2019echa JM, Ferrell RE, Perkins DJ (2010) A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia. Infect Immun 78:453\u2013460","journal-title":"Infect Immun"},{"key":"1175_CR50","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1128\/IAI.67.9.4977-4981.1999","volume":"67","author":"DJ Perkins","year":"1999","unstructured":"Perkins DJ, Kremsner PG, Schmid D, Misukonis MA, Kelly MA, Weinberg JB (1999) Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy Gabonese children with prior mild or severe malaria. Infect Immun 67:4977\u20134981","journal-title":"Infect Immun"},{"key":"1175_CR51","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.7150\/ijbs.7.1427","volume":"7","author":"DJ Perkins","year":"2011","unstructured":"Perkins DJ, Were T, Davenport GC, Kempaiah P, Hittner JB, Ong\u2019echa JM (2011) Severe malarial anemia: innate immunity and pathogenesis. Int J Biol Sci 7:1427\u20131442","journal-title":"Int J Biol Sci"},{"key":"1175_CR52","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1182\/blood.V85.12.3487.bloodjournal85123487","volume":"85","author":"O Sakamoto","year":"1995","unstructured":"Sakamoto O, Hashiyama M, Minty A, Ando M, Suda T (1995) Interleukin-13 selectively suppresses the growth of human macrophage progenitors at the late stage. Blood 85:3487\u20133493","journal-title":"Blood"},{"key":"1175_CR53","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","volume":"14","author":"CE Samuel","year":"2001","unstructured":"Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14:778\u2013809","journal-title":"Clin Microbiol Rev"},{"key":"1175_CR54","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/pro.5560040406","volume":"4","author":"MH Seto","year":"1995","unstructured":"Seto MH, Harkins RN, Adler M, Whitlow M, Church WB, Croze E (1995) Homology model of human interferon-alpha 8 and its receptor complex. Protein Sci 4:655\u2013670","journal-title":"Protein Sci"},{"key":"1175_CR55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.mrfmmm.2006.06.011","volume":"601","author":"IH Song","year":"2006","unstructured":"Song IH, Toan NL, Xuan NT, Uhlemann AC, Boldt AB, Duy DN, Binh VQ, Kremsner PG, Kun JF (2006) A promoter polymorphism in the interferon alpha-2 gene is associated with the clinical presentation of hepatitis B. Mutat Res 601:137\u2013143","journal-title":"Mutat Res"},{"key":"1175_CR56","first-page":"23","volume":"25","author":"JL Taylor","year":"1998","unstructured":"Taylor JL, Grossberg SE (1998) The effects of interferon-alpha on the production and action of other cytokines. Semin Oncol 25:23\u201329","journal-title":"Semin Oncol"},{"key":"1175_CR57","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2156-9-80","volume":"9","author":"C Tena-Tomas","year":"2008","unstructured":"Tena-Tomas C, de Messias-Reason I, le Song H, Tomiuk J, Kemsner PG, Kun JF (2008) A globally occurring indel polymorphism in the promoter of the IFNA2 gene is not associated with severity of malaria but with the positivity rate of HCV. BMC Genet 9:80","journal-title":"BMC Genet"},{"key":"1175_CR58","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1182\/blood.V97.12.3966","volume":"97","author":"AM Vigario","year":"2001","unstructured":"Vigario AM, Belnoue E, Cumano A, Marussig M, Miltgen F, Landau I, Mazier D, Gresser I, Renia L (2001) Inhibition of Plasmodium yoelii blood-stage malaria by interferon alpha through the inhibition of the production of its target cell, the reticulocyte. Blood 97:3966\u20133971","journal-title":"Blood"},{"key":"1175_CR59","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.4049\/jimmunol.178.10.6416","volume":"178","author":"AM Vigario","year":"2007","unstructured":"Vigario AM, Belnoue E, Gruner AC, Mauduit M, Kayibanda M, Deschemin JC, Marussig M, Snounou G, Mazier D, Gresser I, Renia L (2007) Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice. J Immunol 178:6416\u20136425","journal-title":"J Immunol"},{"key":"1175_CR60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2006.08.008","volume":"25","author":"J Vilcek","year":"2006","unstructured":"Vilcek J (2006) Fifty years of interferon research: aiming at a moving target. Immunity 25:343\u2013348","journal-title":"Immunity"},{"key":"1175_CR61","first-page":"1396","volume":"91","author":"T Were","year":"2006","unstructured":"Were T, Hittner JB, Ouma C, Otieno RO, Orago AS, Ong\u2019echa JM, Vulule JM, Keller CC, Perkins DJ (2006) Suppression of RANTES in children with Plasmodium falciparum malaria. Haematologica 91:1396\u20131399","journal-title":"Haematologica"},{"key":"1175_CR62","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.micinf.2009.04.021","volume":"11","author":"T Were","year":"2009","unstructured":"Were T, Davenport GC, Yamo EO, Hittner JB, Awandare GA, Otieno MF, Ouma C, Orago AS, Vulule JM, Ong\u2019echa JM, Perkins DJ (2009) Naturally acquired hemozoin by monocytes promotes suppression of RANTES in children with malarial anemia through an IL-10-dependent mechanism. Microbes Infect 11:811\u2013819","journal-title":"Microbes Infect"},{"key":"1175_CR63","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/JCM.01864-10","volume":"49","author":"T Were","year":"2011","unstructured":"Were T, Davenport GC, Hittner JB, Ouma C, Vulule JM, Ong\u2019echa JM, Perkins DJ (2011) Bacteremia in Kenyan children presenting with malaria. J Clin Microbiol 49:671\u2013676","journal-title":"J Clin Microbiol"},{"key":"1175_CR64","first-page":"S1","volume":"94","author":"WHO","year":"2000","unstructured":"WHO (2000) Centers for Disease Control and Prevention. Severe falciparum malaria. Trans R Soc Trop Med Hyg 94:S1\u2013S90","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1175_CR65","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/beha.1999.0072","volume":"13","author":"SN Wickramasinghe","year":"2000","unstructured":"Wickramasinghe SN, Abdalla SH (2000) Blood and bone marrow changes in malaria. Baillieres Best Pract Res Clin Haematol 13:277\u2013299","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"key":"1175_CR66","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2141.1995.tb05216.x","volume":"90","author":"X Xi","year":"1995","unstructured":"Xi X, Schlegel N, Caen JP, Minty A, Fournier S, Caput D, Ferrara P, Han ZC (1995) Differential effects of recombinant human interleukin-13 on the in vitro growth of human haemopoietic progenitor cells. Br J Haematol 90:921\u2013927","journal-title":"Br J Haematol"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-012-1175-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00439-012-1175-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-012-1175-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T14:56:17Z","timestamp":1687445777000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00439-012-1175-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,9]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["1175"],"URL":"https:\/\/doi.org\/10.1007\/s00439-012-1175-1","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,9]]}}}